Teva to recall certain blood pressure medicine in U.S.
Teva Pharmaceutical Industries Ltd is recalling certain combinations of blood pressure drug valsartan in the United States following the detection of a probable cancer-causing impurity, the latest global recall of…
Nagaland Pharmacy Council To Approach State Govt To Cancel Licences Run By Unqualified People
The Nagaland State Pharmacy Council (NSPC) will soon approach the state government demanding immediate intervention of the Chief Minister and the Health Minister in putting an end to issuing drug…
Sun Pharma, subsidiary enter settlements in Modafinil antitrust litigation
New Delhi: Drug major Sun Pharmaceutical Industries Monday said the company along with its subsidiary has entered into settlements with certain plaintiffs in the Modafinil antitrust litigation pending in the…
Loxo, Bayer drug for cancers driven by rare mutation gets U.S. nod
A Loxo Oncology Inc drug shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation has won U.S. approval, the Food and Drug…
Sun Pharma to acquire Japan’s Pola Pharma for USD 1 mn
New Delhi: Sun Pharma Monday said it will acquire Japan-based Pola Pharma for around USD 1 million to strengthen its presence in dermatology segment across the globe. The company has…
No olive branch extended in brand name case
A company uses ‘Pure Olive Oil’ as part of its trademark; HC refuses to lift injunction on rival. An injunction was stayed against a Bengaluru-based company barred from using the…
Announced 3.5 years ago, NIPER remains on paper
Nagpur: The local pharma fraternity had erupted in joy when Union minister Arun Jaitley announced setting up of National Institute of Pharmaceutical Education and Research (NIPER) in the city on…
Fear of side-effects, higher cost of medicine hampering treatment
KOCHI: Almost 30% of patients with diabetes make combined use of alternative medicines in state. Only 61% stick exclusively to modern medicine and 9% use only alternative medicine. The main…
Pharmacy gets shot in arm
AHMEDABAD: The state being hub of pharmaceutical industry, it does not come as a surprise that the majority of 5,000-odd seats for the Bachelor of Pharmacy (BPharm) were filled for…
Novartis gets European approval for sight therapy Luxturna
ZURICH: Novartis on Friday said it had received European Union approval for its Luxturna gene therapy to restore sight to people with a rare retinal disease. Luxturna is a one-time…
